AMERIPRISE FINANCIAL INC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$120,279
-86.2%
26,435
-81.5%
0.00%
Q1 2023$873,809
-89.6%
143,013
-89.1%
0.00%
-100.0%
Q4 2022$8,378,000
-65.2%
1,311,260
-47.8%
0.00%
-66.7%
Q3 2022$24,064,000
-27.6%
2,512,167
-16.5%
0.01%
-25.0%
Q2 2022$33,231,000
-20.9%
3,010,014
+19.4%
0.01%0.0%
Q1 2022$41,985,000
-11.0%
2,521,505
+2.1%
0.01%
-7.7%
Q4 2021$47,150,000
-12.0%
2,469,709
+13.7%
0.01%
-23.5%
Q3 2021$53,577,000
+60.0%
2,171,600
+68.8%
0.02%
+70.0%
Q2 2021$33,476,000
+132.7%
1,286,447
+183.2%
0.01%
+100.0%
Q1 2021$14,384,000
-8.2%
454,323
+34.6%
0.01%
-16.7%
Q4 2020$15,671,000
+93.8%
337,508
+37.4%
0.01%
+100.0%
Q3 2020$8,087,000
+2669.5%
245,665
+2155.9%
0.00%
Q2 2020$292,000
+29.8%
10,890
+19.9%
0.00%
Q1 2020$225,000
-81.3%
9,080
-87.2%
0.00%
-100.0%
Q1 2018$1,203,00071,2010.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MHR Fund Management 19,997,103$90,986,81911.15%
MPM BioImpact LLC 3,287,397$14,957,6563.99%
Perceptive Advisors 11,962,938$54,431,3671.82%
CM Management, LLC 200,000$910,0000.97%
Velan Capital Investment Management LP 250,000$1,137,5000.92%
Opaleye Management Inc. 610,000$2,775,5000.90%
Boxer Capital, LLC 3,705,133$16,858,3550.90%
SECTORAL ASSET MANAGEMENT INC 985,000$4,481,7500.87%
Parametrica Management Ltd 95,400$434,0700.73%
683 Capital Management, LLC 2,050,000$9,327,5010.72%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders